Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination

Fu Hsiung Su, Shu Hsing Cheng, Chung Yi Li, Jong Dar Chen, Chih Yin Hsiao, Chih Ching Chien, Ya Chuan Yang, Hsiu Hsing Hung, Fang Yeh Chu

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The long-term protective effect of hepatitis B virus (HB) vaccination against HB infection and the necessity for routine booster vaccination in young-adult age subsequent to full HB immunization at birth remain issues of some debate currently. This study is aimed at evaluating the seroprevalence of HB infection and the response to HB booster vaccination amongst young-adult university students who had previously undergone full vaccination during their infancy. Eight hundred and forty-three subjects (mean age 18.7 ± 0.4 years), 492 males and 351 females, with a complete HB vaccination during infancy were enrolled into this study. The prevalence of natural HB infection, chronic HB-carrier status, and HB-naïve group was, respectively, 4.1%, 1.4%, and 62.3%. Amongst 316 study subjects who were naïve to HB infection and had received one HB booster at time of university entrance health examination, 49.6%, 91.4%, and 97.5% of the participants with a serum anti-HBs level

Original languageEnglish
Pages (from-to)8085-8090
Number of pages6
JournalVaccine
Volume25
Issue number47
DOIs
Publication statusPublished - Nov 19 2007
Externally publishedYes

Fingerprint

Hepatitis B virus
hepatitis B
Seroepidemiologic Studies
infancy
Hepatitis B
young adults
seroprevalence
Young Adult
Vaccination
vaccination
Virus Diseases
infection
Orthohepadnavirus
chronic hepatitis B
carrier state
college students
Chronic Hepatitis B
protective effect
immunization
Immunization

Keywords

  • Booster dose
  • Hepatitis B antibodies
  • Hepatitis B vaccination
  • Taiwan

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. / Su, Fu Hsiung; Cheng, Shu Hsing; Li, Chung Yi; Chen, Jong Dar; Hsiao, Chih Yin; Chien, Chih Ching; Yang, Ya Chuan; Hung, Hsiu Hsing; Chu, Fang Yeh.

In: Vaccine, Vol. 25, No. 47, 19.11.2007, p. 8085-8090.

Research output: Contribution to journalArticle

Su, Fu Hsiung ; Cheng, Shu Hsing ; Li, Chung Yi ; Chen, Jong Dar ; Hsiao, Chih Yin ; Chien, Chih Ching ; Yang, Ya Chuan ; Hung, Hsiu Hsing ; Chu, Fang Yeh. / Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. In: Vaccine. 2007 ; Vol. 25, No. 47. pp. 8085-8090.
@article{756a7c9289d14cfd958ac22506ff59f2,
title = "Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination",
abstract = "The long-term protective effect of hepatitis B virus (HB) vaccination against HB infection and the necessity for routine booster vaccination in young-adult age subsequent to full HB immunization at birth remain issues of some debate currently. This study is aimed at evaluating the seroprevalence of HB infection and the response to HB booster vaccination amongst young-adult university students who had previously undergone full vaccination during their infancy. Eight hundred and forty-three subjects (mean age 18.7 ± 0.4 years), 492 males and 351 females, with a complete HB vaccination during infancy were enrolled into this study. The prevalence of natural HB infection, chronic HB-carrier status, and HB-na{\"i}ve group was, respectively, 4.1{\%}, 1.4{\%}, and 62.3{\%}. Amongst 316 study subjects who were na{\"i}ve to HB infection and had received one HB booster at time of university entrance health examination, 49.6{\%}, 91.4{\%}, and 97.5{\%} of the participants with a serum anti-HBs level",
keywords = "Booster dose, Hepatitis B antibodies, Hepatitis B vaccination, Taiwan",
author = "Su, {Fu Hsiung} and Cheng, {Shu Hsing} and Li, {Chung Yi} and Chen, {Jong Dar} and Hsiao, {Chih Yin} and Chien, {Chih Ching} and Yang, {Ya Chuan} and Hung, {Hsiu Hsing} and Chu, {Fang Yeh}",
year = "2007",
month = "11",
day = "19",
doi = "10.1016/j.vaccine.2007.09.013",
language = "English",
volume = "25",
pages = "8085--8090",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "47",

}

TY - JOUR

T1 - Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination

AU - Su, Fu Hsiung

AU - Cheng, Shu Hsing

AU - Li, Chung Yi

AU - Chen, Jong Dar

AU - Hsiao, Chih Yin

AU - Chien, Chih Ching

AU - Yang, Ya Chuan

AU - Hung, Hsiu Hsing

AU - Chu, Fang Yeh

PY - 2007/11/19

Y1 - 2007/11/19

N2 - The long-term protective effect of hepatitis B virus (HB) vaccination against HB infection and the necessity for routine booster vaccination in young-adult age subsequent to full HB immunization at birth remain issues of some debate currently. This study is aimed at evaluating the seroprevalence of HB infection and the response to HB booster vaccination amongst young-adult university students who had previously undergone full vaccination during their infancy. Eight hundred and forty-three subjects (mean age 18.7 ± 0.4 years), 492 males and 351 females, with a complete HB vaccination during infancy were enrolled into this study. The prevalence of natural HB infection, chronic HB-carrier status, and HB-naïve group was, respectively, 4.1%, 1.4%, and 62.3%. Amongst 316 study subjects who were naïve to HB infection and had received one HB booster at time of university entrance health examination, 49.6%, 91.4%, and 97.5% of the participants with a serum anti-HBs level

AB - The long-term protective effect of hepatitis B virus (HB) vaccination against HB infection and the necessity for routine booster vaccination in young-adult age subsequent to full HB immunization at birth remain issues of some debate currently. This study is aimed at evaluating the seroprevalence of HB infection and the response to HB booster vaccination amongst young-adult university students who had previously undergone full vaccination during their infancy. Eight hundred and forty-three subjects (mean age 18.7 ± 0.4 years), 492 males and 351 females, with a complete HB vaccination during infancy were enrolled into this study. The prevalence of natural HB infection, chronic HB-carrier status, and HB-naïve group was, respectively, 4.1%, 1.4%, and 62.3%. Amongst 316 study subjects who were naïve to HB infection and had received one HB booster at time of university entrance health examination, 49.6%, 91.4%, and 97.5% of the participants with a serum anti-HBs level

KW - Booster dose

KW - Hepatitis B antibodies

KW - Hepatitis B vaccination

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=35448997829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448997829&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2007.09.013

DO - 10.1016/j.vaccine.2007.09.013

M3 - Article

VL - 25

SP - 8085

EP - 8090

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 47

ER -